These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 22785434

  • 1. Efficacy and safety of periprocedural dabigatran in patients undergoing catheter ablation of atrial fibrillation.
    Kaseno K, Naito S, Nakamura K, Sakamoto T, Sasaki T, Tsukada N, Hayano M, Nishiuchi S, Fuke E, Miki Y, Nakamura K, Yamashita E, Kumagai K, Oshima S, Tada H.
    Circ J; 2012; 76(10):2337-42. PubMed ID: 22785434
    [Abstract] [Full Text] [Related]

  • 2. Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation.
    Maddox W, Kay GN, Yamada T, Osorio J, Doppalapudi H, Plumb VJ, Gunter A, McElderry HT.
    J Cardiovasc Electrophysiol; 2013 Aug; 24(8):861-5. PubMed ID: 23577951
    [Abstract] [Full Text] [Related]

  • 3. Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
    Lakkireddy D, Reddy YM, Di Biase L, Vanga SR, Santangeli P, Swarup V, Pimentel R, Mansour MC, D'Avila A, Sanchez JE, Burkhardt JD, Chalhoub F, Mohanty P, Coffey J, Shaik N, Monir G, Reddy VY, Ruskin J, Natale A.
    J Am Coll Cardiol; 2012 Mar 27; 59(13):1168-74. PubMed ID: 22305113
    [Abstract] [Full Text] [Related]

  • 4. Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation.
    Bassiouny M, Saliba W, Rickard J, Shao M, Sey A, Diab M, Martin DO, Hussein A, Khoury M, Abi-Saleh B, Alam S, Sengupta J, Borek PP, Baranowski B, Niebauer M, Callahan T, Varma N, Chung M, Tchou PJ, Kanj M, Dresing T, Lindsay BD, Wazni O.
    Circ Arrhythm Electrophysiol; 2013 Jun 27; 6(3):460-6. PubMed ID: 23553523
    [Abstract] [Full Text] [Related]

  • 5. Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation.
    Kim JS, She F, Jongnarangsin K, Chugh A, Latchamsetty R, Ghanbari H, Crawford T, Suwanagool A, Sinno M, Carrigan T, Kennedy R, Saint-Phard W, Yokokawa M, Good E, Bogun F, Pelosi F, Morady F, Oral H.
    Heart Rhythm; 2013 Apr 27; 10(4):483-9. PubMed ID: 23237911
    [Abstract] [Full Text] [Related]

  • 6. Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter.
    Kaiser DW, Streur MM, Nagarakanti R, Whalen SP, Ellis CR.
    J Interv Card Electrophysiol; 2013 Sep 27; 37(3):241-7. PubMed ID: 23625091
    [Abstract] [Full Text] [Related]

  • 7. Feasibility and safety of uninterrupted dabigatran therapy in patients undergoing ablation for atrial fibrillation.
    Nagao T, Inden Y, Shimano M, Fujita M, Yanagisawa S, Kato H, Ishikawa S, Miyoshi A, Okumura S, Ohguchi S, Yamamoto T, Yoshida N, Hirai M, Murohara T.
    Intern Med; 2015 Sep 27; 54(10):1167-73. PubMed ID: 25986252
    [Abstract] [Full Text] [Related]

  • 8. Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.
    Armbruster HL, Lindsley JP, Moranville MP, Habibi M, Khurram IM, Spragg DD, Berger RD, Calkins H, Marine JE.
    Ann Pharmacother; 2015 Mar 27; 49(3):278-84. PubMed ID: 25515868
    [Abstract] [Full Text] [Related]

  • 9. Dabigatran in the peri-procedural period for radiofrequency ablation of atrial fibrillation: efficacy, safety, and impact on duration of hospital stay.
    Imamura K, Yoshida A, Takei A, Fukuzawa K, Kiuchi K, Takami K, Takami M, Itoh M, Fujiwara R, Suzuki A, Nakanishi T, Yamashita S, Matsumoto A, Hirata K.
    J Interv Card Electrophysiol; 2013 Sep 27; 37(3):223-31. PubMed ID: 23585240
    [Abstract] [Full Text] [Related]

  • 10. Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies.
    Steinberg BA, Hasselblad V, Atwater BD, Bahnson TD, Washam JB, Alexander JH, Daubert JP, Piccini JP.
    J Interv Card Electrophysiol; 2013 Sep 27; 37(3):213-21. PubMed ID: 23881249
    [Abstract] [Full Text] [Related]

  • 11. Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation.
    Stepanyan G, Badhwar N, Lee RJ, Marcus GM, Lee BK, Tseng ZH, Vedantham V, Olgin J, Scheinman M, Gerstenfeld EP.
    J Interv Card Electrophysiol; 2014 Jun 27; 40(1):33-8. PubMed ID: 24643666
    [Abstract] [Full Text] [Related]

  • 12. A randomized controlled trial of dabigatran versus warfarin for periablation anticoagulation in patients undergoing ablation of atrial fibrillation.
    Nin T, Sairaku A, Yoshida Y, Kamiya H, Tatematsu Y, Nanasato M, Inden Y, Hirayama H, Murohara T.
    Pacing Clin Electrophysiol; 2013 Feb 27; 36(2):172-9. PubMed ID: 23121681
    [Abstract] [Full Text] [Related]

  • 13. Periprocedural dabigatran in atrial fibrillation ablation: a new kid on the block.
    Pelargonio G, Perna F.
    J Cardiovasc Electrophysiol; 2013 Aug 27; 24(8):866-8. PubMed ID: 23647979
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differences in intraprocedural ACTs with standardized heparin dosing during catheter ablation for atrial fibrillation in patients treated with dabigatran vs. patients on uninterrupted warfarin.
    Konduru SV, Cheema AA, Jones P, Li Y, Ramza B, Wimmer AP.
    J Interv Card Electrophysiol; 2012 Dec 27; 35(3):277-84; discussion 284. PubMed ID: 23015216
    [Abstract] [Full Text] [Related]

  • 18. Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation.
    Providência R, Marijon E, Albenque JP, Combes S, Combes N, Jourda F, Hireche H, Morais J, Boveda S.
    Europace; 2014 Aug 27; 16(8):1137-44. PubMed ID: 24550347
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of dabigatran compared with warfarin for patients undergoing radiofrequency catheter ablation of atrial fibrillation: a meta-analysis.
    Shurrab M, Morillo CA, Schulman S, Kansal N, Danon A, Newman D, Lashevsky I, Healey JS, Crystal E.
    Can J Cardiol; 2013 Oct 27; 29(10):1203-10. PubMed ID: 23993352
    [Abstract] [Full Text] [Related]

  • 20. Meta-analysis of risk of stroke or transient ischemic attack with dabigatran for atrial fibrillation ablation.
    Sardar P, Nairooz R, Chatterjee S, Wetterslev J, Ghosh J, Aronow WS.
    Am J Cardiol; 2014 Apr 01; 113(7):1173-7. PubMed ID: 24513472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.